Evidence map›Paper›PMID 31295334›Full record

ArticlePLoS pathogens2019

Controlled human malaria infection with Plasmodium falciparum demonstrates impact of naturally acquired immunity on virulence gene expression.

Anna Bachmann, Ellen Bruske, Ralf Krumkamp, Louise Turner, J Stephan Wichers, Michaela Petter, Jana Held, Michael F Duffy, B Kim Lee Sim, Stephen L Hoffman and 6 more

Erratum issuedOpen access · goldAbstract readControlled Clinical Trial
In one paragraph

Article in PLoS pathogens, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 36 papers.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed
7.5field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 52 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Evolutionary Trajectory ofBiomedicines · 2025
    Review
  6. Article
  7. Article
  8. Variable surface antigen expression, virulence, and persistent infection byMicrobiology and molecular biology reviews : MMBR · 2025
    Review
  9. Article
  10. Frontiers in cellular and infection microbiology · 2025
    Review
  11. Article
  12. Review
  13. Review
  14. The human malaria parasiteProceedings of the National Academy of Sciences of the United States of America · 2023
    Article
  15. Article
  16. Review
  17. Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

16 authors at 7 institutions in 5 countries.

Anna BachmannDepartment of Molecular Parasitology, Bernhard Nocht Institute for Tropical Medicine, Hamburg, Germany.ORCID 0000-0001-8397-7308
Ellen BruskeInstitute of Tropical Medicine, University Hospital Tübingen, Tübingen, Germany.
Ralf KrumkampGerman Center for Infection Research (DZIF), partner site Hamburg-Borstel-Lübeck-Riems, Germany.ORCID 0000-0003-3053-476X
Louise TurnerCentre for Medical Parasitology, University of Copenhagen, Copenhagen K, Denmark.
J Stephan WichersDepartment of Molecular Parasitology, Bernhard Nocht Institute for Tropical Medicine, Hamburg, Germany.ORCID 0000-0002-0599-1742
Michaela PetterMikrobiologisches Institut-Klinische Mikrobiologie, Immunologie und Hygiene, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität (FAU) Erlangen-Nürnberg, Erlangen, Germany.
Jana HeldInstitute of Tropical Medicine, University Hospital Tübingen, Tübingen, Germany.
Michael F DuffySchool of BioSciences, Bio21 Institute, University of Melbourne, Parkville, Victoria, Australia.
B Kim Lee SimSanaria Inc., Rockville, MD, United States of America.ORCID 0000-0002-8598-8905
Stephen L HoffmanSanaria Inc., Rockville, MD, United States of America.
Peter G KremsnerInstitute of Tropical Medicine, University Hospital Tübingen, Tübingen, Germany.
Bertrand LellInstitute of Tropical Medicine, University Hospital Tübingen, Tübingen, Germany.
Thomas LavstsenCentre for Medical Parasitology, University of Copenhagen, Copenhagen K, Denmark.
Matthias FrankInstitute of Tropical Medicine, University Hospital Tübingen, Tübingen, Germany.
Benjamin MordmüllerInstitute of Tropical Medicine, University Hospital Tübingen, Tübingen, Germany.
Egbert TannichDepartment of Molecular Parasitology, Bernhard Nocht Institute for Tropical Medicine, Hamburg, Germany.
German Center for Infection Research · DEUniversity Children's Hospital Tübingen · DESanaria · USThe University of Melbourne · AUUniversity of Copenhagen · DKBernhard Nocht Institute for Tropical Medicine · DECentre de Recherche Médicales de Lambaréné · GA

Funding

Plasmodium Falciparum Whole Sporozoite Malaria VaccineR44AI055229 · NIAID · SANARIA, INC. · PI HOFFMAN, STEPHEN LEV · 2005 to 2015
$10.0M
Universal Attenuated Sporozoite Vaccine and Challenge SystemR44AI058375 · NIAID · SANARIA, INC. · PI HOFFMAN, STEPHEN LEV · 2006 to 2018
$9.9M
NIAID NIH HHS R44 AI055229NIAID NIH HHS R44 AI058375
6 · The paper itself

Abstract

The pathogenesis of Plasmodium falciparum malaria is linked to the variant surface antigen PfEMP1, which mediates tethering of infected erythrocytes to the host endothelium and is encoded by approximately 60 var genes per parasite genome. Repeated episodes of malaria infection result in the gradual acquisition of protective antibodies against PfEMP1 variants. The antibody repertoire is believed to provide a selective pressure driving the clonal expansion of parasites expressing unrecognized PfEMP1 variants, however, due to the lack of experimental in vivo models there is only limited experimental evidence in support of this concept. To get insight into the impact of naturally acquired immunity on the expressed var gene repertoire early during infection we performed controlled human malaria infections of 20 adult African volunteers with life-long malaria exposure using aseptic, purified, cryopreserved P. falciparum sporozoites (Sanaria PfSPZ Challenge) and correlated serological data with var gene expression patterns from ex vivo parasites. Among the 10 African volunteers who developed patent infections, individuals with low antibody levels showed a steep rise in parasitemia accompanied by broad activation of multiple, predominantly subtelomeric var genes, similar to what we previously observed in naïve volunteers. In contrast, individuals with intermediate antibody levels developed asymptomatic infections and the ex vivo parasite populations expressed only few var gene variants, indicative of clonal selection. Importantly, in contrast to parasites from naïve volunteers, expression of var genes coding for endothelial protein C receptor (EPCR)-binding PfEMP1 that are associated with severe childhood malaria was rarely detected in semi-immune adult African volunteers. Moreover, we followed var gene expression for up to six parasite replication cycles and demonstrated for the first time in vivo a shift in the dominant var gene variant. In conclusion, our data suggest that P. falciparum activates multiple subtelomeric var genes at the onset of blood stage infection facilitating rapid expansion of parasite clones which express PfEMP1 variants unrecognized by the host's immune system, thus promoting overall parasite survival in the face of host immunity.

Indexed as

AdolescentAdultAnimalsAntibodies, ProtozoanFemaleGene Expression RegulationGenes, ProtozoanHumansImmunity, InnateMalaria, FalciparumMalePlasmodium falciparumProtozoan ProteinsVirulenceYoung AdultAntibodies, Protozoanerythrocyte membrane protein 1, Plasmodium falciparumProtozoan Proteins

Identifiers

PMID31295334
PMCPMC6650087
OpenAlexW2962225605

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.